Steven Elms

Steven Elms

Président chez ADMA BIOLOGICS, INC.

Fortune : 701 553 $ au 31/05/2026

62 ans
Health Technology
Finance
Health Services

Profil

Mr. Steven A. Elms is an Independent Director at Marker Therapeutics, Inc., a Chairman at ADMA Biologics, Inc., a Managing Partner at Aisling Capital LLC, a Managing Member at Aisling Capital Partners LLC and a Member-INVO Board at Northwestern University.
He is on the Board of Directors at Marker Cell Therapy, Inc., Marker Therapeutics, Inc., Ajax Health LLC, Ajax Health II LLC and Treeline Biosciences, Inc. Mr. Elms was previously employed as a Chairman by Elevation Oncology, Inc., an Independent Director by Zosano Pharma Corp., an Independent Director by Cidara Therapeutics, Inc., an Independent Director by Loxo Oncology, Inc., an Independent Non-Executive Director by Pernix Therapeutics Holdings, Inc., a Chairman by MAP Pharmaceuticals, Inc., a Chairman by Adams Respiratory Therapeutics, Inc., a Principal-Life Sciences Investment Banking Group by Hambrecht & Quist, a Principal by Hambrecht & Quist Group, a Co-Chairman by LENSAR, Inc., a Principal by Marion Laboratories, a Chairman by Oculex Pharmaceuticals, Inc., and a Consultant by Wilkerson Group.
He also served on the board at Bioenvision, Inc., Ambit Biosciences Corp., Advion BioSciences, Inc., Advion, Inc., Archimica Cooperatief UA, Avera Pharmaceuticals, Inc., CeNeRx BioPharma, Inc., Earlens Corp., Medical Knowledge Group LLC, NextWave Pharmaceuticals, Inc., Novazyme Pharmaceuticals, Inc., Scerene Healthcare, Inc. and TRIA Beauty, Inc. He received his undergraduate degree from Stanford University and an MBA from Kellogg School of Management.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
31/03/2026 87 330 ( 0,04 % ) 696 893 $ 31/05/2026
01/03/2026 2 968 ( 0,02 % ) 4 660 $ 31/05/2026

Postes actifs de Steven Elms

SociétésPosteDébut
ADMA BIOLOGICS, INC. Président 30/03/2012
MARKER THERAPEUTICS, INC. Directeur/Membre du Conseil 06/08/2019
Aisling Capital Partners LLC
Corporate Officer/Principal -
Directeur/Membre du Conseil 06/08/2019
Corporate Officer/Principal -
Directeur/Membre du Conseil -
Directeur/Membre du Conseil -
Directeur/Membre du Conseil -
Private Equity Investor 01/07/2000

Anciens postes connus de Steven Elms

SociétésPosteFin
░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░ ░░░░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
░░░░ ░░░░░░░░ ░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░░░░░░░ ░░░░░░░░ ░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
Voir l'expérience en détail de Steven Elms

Formation de Steven Elms

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

60

Relations au 1er degré

37

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées37

Finance

Health Services

Health Technology

Commercial Services

Health Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Finance

Health Technology

Health Technology

Aisling Capital Partners LLC

Health Technology

Health Technology

Consumer Services

Commercial Services

Health Services

Health Technology

Consumer Services

Distribution Services

Health Technology

Health Services

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Hambrecht & Quist

Finance

Commercial Services

Finance

Health Technology

Health Technology

  1. Bourse
  2. Insiders
  3. Steven Elms
- 40% : Les Meilleurs Outils Réservés aux Abonnés pour Identifier les Meilleurs Investissements de Demain !
j
:
:
PROFITEZ-EN MAINTENANT
🔇